{"id":127253,"date":"2015-09-22T15:43:16","date_gmt":"2015-09-22T15:43:16","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=127253"},"modified":"2015-09-22T15:43:16","modified_gmt":"2015-09-22T15:43:16","slug":"un-medicament-vital-pentru-bolnavii-de-sida-si-de-cancer-s-a-scumpit-de-55-de-ori-cel-care-a-luat-decizia-a-devenit-inamicul-public-numarul-1-in-sua-foto","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=127253","title":{"rendered":"Un medicament vital pentru bolnavii de SIDA \u015fi de cancer s-a scumpit de 55 de ori. Cel care a luat decizia a devenit inamicul public num\u0103rul 1 \u00een SUA &#8211; FOTO"},"content":{"rendered":"<p style=\"text-align: justify;\">\nCompania Turing Pharmaceuticals&nbsp;a cump\u0103rat dreptul de a produce medicamentul \u00een august 2015 \u00een schimbul sumei de 55 milioane de dolari. Costul de produc\u0163ie al unei pastile este de doar 1 dolar, dar a ajuns s\u0103 se v\u00e2nd\u0103 cu 13,5 dolari \u00een urma schimb\u0103rii succesive de produc\u0103tor. Fondatorul Turing Pharmaceuticals, Martin Shkreli, a decis \u00eens\u0103, la scurt timp dup\u0103 ce a devenit de\u0163in\u0103torul patentului, c\u0103 pre\u0163ul corect ar fi de 750 de dolari pentru o pastil\u0103, potrivit&nbsp;<a href=\"http:\/\/www.dailymail.co.uk\/home\/index.html\">Daily Mail<\/a>.<\/p>\n<p style=\"text-align: justify;\">\nDaraprim este pe pia\u0163\u0103 de peste 60 de ani \u015fi se afl\u0103 pe lista de medicamente esen\u0163iale a Organiza\u0163iei Mondiale a S\u0103n\u0103t\u0103\u0163ii. Medicamentul este folosit \u00een tratamentul toxoplasmozei, una dintre&nbsp;una dintre cele mai frecvente infec\u0163ii parazitare care \u00eei afecteaz\u0103 \u00een principal pe copii \u015fi pe cei cu sistemul imunitar compromis, cum sunt cei care sufer\u0103 de SIDA sau cancer.&nbsp;<\/p>\n<p style=\"text-align: justify;\">\nDecizia companiei americare a st\u00e2rnit consternare \u00een r\u00e2ndul medicilor din SUA. Dou\u0103 asocia\u0163ii profesionale &#8211; Societatea American\u0103 de Boli Infec\u0163ioase (IDSA)&nbsp;\u015fi Asocia\u0163ia pentru Tratamentul HIV (HIVMA)&nbsp;au semnat o scrisoare deschis\u0103 \u00een care \u00ee\u015fi exprim\u0103 \u00eengrijorarea \u00een leg\u0103tur\u0103 cu pre\u0163ul prohibitiv al acestui medicament \u015fi cer ca Turing s\u0103 revin\u0103 asupra deciziei de a scumpi medicamentul.<\/p>\n<p style=\"text-align: justify;\">\n&#8220;Noul cost este nu se justific\u0103,&nbsp;&nbsp;pune via\u0163a bolnavilor \u00een pericol, iar cre\u015fterea este nesustenabil\u0103 pentru sistemul public de s\u0103n\u0103tate&#8221;, se arat\u0103 \u00een scrisoare.<\/p>\n<p style=\"text-align: justify;\">\nO pozi\u0163ie asem\u0103n\u0103toare a avut \u015fi Hillary Clinton, care a scris pe Twitter c\u0103 scumpirea este &#8220;strig\u0103toare la cer&#8221;.&nbsp;<\/p>\n<p style=\"text-align: justify;\">\nReac\u0163ii injurioase la adresa lui Shkreli din partea oamenilor au curs \u00een ultimele zile pe toate re\u0163elele de socializare. Acestea s-au amplificat dup\u0103 ce fondatorul&nbsp;Turing Pharmaceuticals a declarat c\u0103 nu are de g\u00e2nd s\u0103 revin\u0103 asupra deciziei \u015fi c\u0103 firma pe care o de\u0163ine trebuie s\u0103 fac\u0103 profit.<\/p>\n<p style=\"text-align: center;\">\n<img decoding=\"async\" alt=\"\" src=\"http:\/\/storage0.dms.mpinteractiv.ro\/media\/401\/341\/5531\/14736797\/2\/mark-shkreli.jpg?height=450&#038;width=600\" style=\"width: 600px; height: 450px; margin: 2px;\" \/><\/p>\n<p style=\"text-align: justify;\">\nEl a negat c\u0103 ar fi vorba de l\u0103comie \u015fi a motivat scumpirea prin nevoia de a investi \u00een cercetare pentru \u00eembun\u0103t\u0103\u0163irea Daraprim. &#8220;Nu este vorba despre o companie lacom\u0103 care \u00eencearc\u0103 s\u0103 jefuiasc\u0103 pacien\u0163ii. Este pur \u015fi simplu o decizie care ne men\u0163ine \u00een afaceri&#8221;, a spus Martin Shkreli.<\/p>\n<p style=\"text-align: justify;\">\n\u00centr-o disput\u0103 cu unul dintre ziari\u015ftii care l-au criticat, &nbsp;Shkreli l-a catalogat pe acesta drept &#8220;idiot&#8221;.<\/p>\n<p style=\"text-align: justify;\">\nOmul de afaceri \u00een v\u00e2rst\u0103 de doar 32 de ani nu este la prima &#8220;manevr\u0103&#8221; de acest gen. El a fost for\u0163at s\u0103 se retrag\u0103 de la conducerea unei alte companii pe care a fondat-o \u015fi care era specializat\u0103 \u00een cump\u0103rarea patentului pentru medicamente ieftine, care ulterior erau scumpite semnificativ.<\/p>\n<p style=\"text-align: center;\">\n<img decoding=\"async\" alt=\"\" src=\"http:\/\/storage0.dms.mpinteractiv.ro\/media\/401\/341\/5531\/14736797\/3\/mark-shkreli1.jpg?height=579&#038;width=400\" style=\"width: 400px; height: 579px; margin: 2px;\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Medicamentul Daraprim, folosit de bolnavii de SIDA \u015fi cancer, s-a scumpit cu 5500%, dup\u0103 ce o companie american\u0103 a decis s\u0103 v\u00e2nd\u0103 o pastil\u0103 cu 750 de dolari \u00een loc de 13,5 dolari, la o lun\u0103 dup\u0103 ce a cump\u0103rat patentul. Aceast\u0103 decizie a st\u00e2rnit consternare \u00een r\u00e2ndul comunit\u0103\u0163ii medicale interna\u0163ionale, transform\u00e2ndu-l pe Martin Shkreli, fondatorul Turing Pharmaceuticals, \u00een cel mai detestat om din industria farmaceutic\u0103, scrie Daily Mail.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[41663,32260,482,35938],"class_list":["post-127253","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-daraprim","tag-medicament","tag-pret","tag-sida"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/127253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=127253"}],"version-history":[{"count":0,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/127253\/revisions"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=127253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=127253"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=127253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}